The CEO of Daxor (DXR) Michael Feldschuh talks about his company, shares of which began trading on the Nasdaq Wednesday, Feb. 2, 2022. Founded in 1971, Daxor is a global leader in blood volume measurement technology and specializes in blood volume testing, which is pivotal to the healthcare industry. The company has a market cap of $45.28M and manufactures the first diagnostic blood test that has been cleared by the FDA
03 Feb 2022
Trading 360
18 Mar 2022
Market On Close
18 May 2022
The Watch List
22 Feb 2022
Trading 360
28 Feb 2022
Morning Trade Live
29 Apr 2022
Morning Trade Live
01 Apr 2022